The report will be delivered in 2-3 business days.

Nucleic Acid Based Gene Therapy Market Global Report 2020

Starting Price : $ 4000.00 $3200.00 | Pages : 200 | Published : April 2020 | SKU CODE : 7614 | Format :


The nucleic acid-based gene therapy market consists of sales of nucleic acid-based gene therapy products and services. Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.

The global nucleic acid based gene therapy market was worth $557.47 million in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 10.00% and reach $816.18 million by 2023.

The nucleic acid-based gene therapy market covered in this report is segmented by technology into anti-sence and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers, others. It is also segmented by application into oncology, muscular dystrophy/ muscular disorders, rare diseases.

Rising financial support by the government and the companies is projected to drive the demand for nucleic acid based gene therapy. Nucleic acid therapeutics are analogs of naturally occurring acids or proteins responsible for genetic expression. The traditional therapies do not have any cure for the treatment of diseases such as cystic fibrosis, hemophilia, sickle cell anaemia, thalassemia, and diabetes. Genetic profiling and molecular target identification form the backbone of these classes of drugs. Nucleic acid medication has greater potential for the treatment of these diseases, as they target the genetic basis of diseases and have a permanent cure. Rising financial support by the government and the companies dealing in the market for gene therapy is expected to contribute to increasing the demand for nucleic acid-based gene therapies. For instance in October 2019, the USA National Institutes of Health (NIH) announced plans to invest $100 million for the next four years to cure HIV and sickle cell disease with gene therapies. The government support for gene therapies will contribute to the growth of the market.

Stringent regulations imposed on gene therapies raises the price of gene therapies, which in turn hinders the demand for nucleic acid-based gene therapies. The excessive regulatory oversights create an expensive and elongated route for approval increasing the expenses. According to Foundation for Economic Education (FEE), unlike other drugs approved or regulated by the Food and Drug Administration (FDA), gene therapies are not only subject to the regulatory structure of FDA, but also the Recombinant DNA Advisory Committee and Office of Biotechnology Activities. Also, as estimated by FEE, an approved gene therapy drug cost nearly $5.0 billion, which is five times higher than that of the average cost of FDA approval. The high cost of gene therapeutics drugs places them beyond the financial reach of the populace. This scenario is anticipated to restrain the market growth of the nucleic acid-based gene therapy market.

In May 2018, Vectalys, a leading biotechnology company specializing in the manufacturing of high-quality solutions for gene delivery and FlashCell, a company engaged in developing non-integrated lentiviral delivered RNA Therapeutics announced the merger to create Flash Therapeutics, a privately held gene therapy company developing cell and gene therapeutics. The new company Flash Therapeutics is expected to focus on the development of RNA therapeutics based on LentiFlash, a non-integrative lentiviral delivery technology for incurable diseases.

The major players in the global nucleic acid based gene therapy market are Celsion Corporation, Wave Life Sciences, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN, BioMedica, Transgene, Copernicus Therapeutics

The countries covered in the global nucleic acid based gene therapy market report are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

The Global Nucleic Acid Based Gene Therapy Market is segmented:
1) By Technology: Anti-Sence and Anti-Gene , Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Others
2) By Application: Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases

    1. Executive Summary

    2. Nucleic Acid Based Gene Therapy Market Characteristics

    3. Nucleic Acid Based Gene Therapy Market Size And Growth

    3.1. Global Nucleic Acid Based Gene Therapy Market Historic Market, 2015 - 2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Nucleic Acid Based Gene Therapy Market Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Nucleic Acid Based Gene Therapy Market Segmentation

    4.1. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Anti-Sence and Anti-Gene  

    Short Inhibitory Sequences

    Gene Transfer Therapy

    Nucleoside Analogs

    Ribozymes

    Aptamers

    Others

    4.2. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Monogenetic Disorders

    Multi-gentic Disorders

    5. Nucleic Acid Based Gene Therapy Market Regional And Country Analysis

    5.1. Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Nucleic Acid Based Gene Therapy Market  

    6.1. Asia-Pacific Nucleic Acid Based Gene Therapy Market Overview  

    6.2. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China Nucleic Acid Based Gene Therapy Market  

    7.1. China Nucleic Acid Based Gene Therapy Market Overview  

    7.2. China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    8. India Nucleic Acid Based Gene Therapy Market  

    8.1. India Nucleic Acid Based Gene Therapy Market Overview  

    8.2. India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan Nucleic Acid Based Gene Therapy Market  

    9.1. Japan Nucleic Acid Based Gene Therapy Market Overview  

    9.2. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia Nucleic Acid Based Gene Therapy Market  

    10.1. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia Nucleic Acid Based Gene Therapy Market  

    11.1. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea Nucleic Acid Based Gene Therapy Market  

    12.1. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe Nucleic Acid Based Gene Therapy Market  

    13.1. Western Europe Nucleic Acid Based Gene Therapy Market Overview

    13.2. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK Nucleic Acid Based Gene Therapy Market  

    14.1. UK Nucleic Acid Based Gene Therapy Market Overview

    14.2. UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany Nucleic Acid Based Gene Therapy Market  

    15.1. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France Nucleic Acid Based Gene Therapy Market  

    16.3. France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe Nucleic Acid Based Gene Therapy Market  

    17.1. Eastern Europe Nucleic Acid Based Gene Therapy Market Overview

    17.2. Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia Nucleic Acid Based Gene Therapy Market  

    18.1. Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America Nucleic Acid Based Gene Therapy Market  

    19.1. North America Nucleic Acid Based Gene Therapy Market Overview

    19.2. North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA Nucleic Acid Based Gene Therapy Market  

    20.1. USA Nucleic Acid Based Gene Therapy Market Overview

    20.2. USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America Nucleic Acid Based Gene Therapy Market  

    21.1. South America Nucleic Acid Based Gene Therapy Market Overview

    21.2. South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil Nucleic Acid Based Gene Therapy Market  

    22.1. Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East Nucleic Acid Based Gene Therapy Market  

    23.1. Middle East Nucleic Acid Based Gene Therapy Market Overview

    23.2. Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa Nucleic Acid Based Gene Therapy Market  

    24.1. Africa Nucleic Acid Based Gene Therapy Market Overview

    24.2. Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. Nucleic Acid Based Gene Therapy Market Competitive Landscape And Company Profiles

    25.1. Nucleic Acid Based Gene Therapy Market Competitive Landscape

    25.2. Nucleic Acid Based Gene Therapy Market Company Profiles

    25.2.1. Celsion Corporation

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Wave Life Sciences

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Imugene

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Caperna

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Phylogica

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Nucleic Acid Based Gene Therapy Market

    27. Nucleic Acid Based Gene Therapy Market Trends And Strategies

    28. Nucleic Acid Based Gene Therapy Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: China, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: India, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: France, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26: Celsion Corporation Financial Performance
  • Table 27: Wave Life Sciences Financial Performance
  • Table 28: Imugene Financial Performance
  • Table 29: Caperna Financial Performance
  • Table 30: Phylogica Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: China, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: India, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: France, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26: Celsion Corporation Financial Performance
  • Figure 27: Wave Life Sciences Financial Performance
  • Figure 28: Imugene Financial Performance
  • Figure 29: Caperna Financial Performance
  • Figure 30: Phylogica Financial Performance
Development Of Alternative Products In The Blood Glucose Test Strips Market- Silk Strips, Continuous Test Tapes
The Refractive Surgery Devices And Equipment Industry Will Reach $1.18 Billion By 2022
High Risk Of Diabetic Patients Suffering From The Coronavirus Has Led To Increased Demand For POC HbA1C Testing
Increasing Adoption Of Neurological Devices Over Drug Therapies
Resmed And General Electric Company- Leaders In The Anesthesia And Respiratory Devices Market
Increase In Collaborations And Partnerships In The Medical Sensors Market
Smart Inhalers And Wearables For Patients Suffering From Respiratory Diseases
Tobacco Smoking, Sleep Apnea, And Changing Climate Conditions Are Increasing The Demand For Respiratory Devices
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2020-30: Covid 19 Growth and Change
View Report
Pulse Oximeters and Spirometers Market - By Product Type (Pulse Oximeters, Spirometers), Type Of Device (Handheld, Fingertip, Others), By Application (Diagnostic, Treatment Monitoring), By Patient Type (Asthma, COPD, Other General & Surgical Practice, Other Respiratory Diseases), By End-Use (Hospitals, Clinical Laboratories, Home Care), Market Size, Opportunities And Strategies - Global Forecast To 2030
View Report
Wearable Blood Pressure Monitors Market - By Product (Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor, Finger Blood Pressure Monitor), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
COVID-19 Rapid Test Kits Market- By Test Type (RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, Others), By Kit Type (PCR Machines, Equipment And Extraction Kits, Reagents), By Specimen Type (Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Blood, Others), By End-Users (Hospitals And Clinics, Diagnostic Laboratories, Home Care, Others), And By Region, Opportunities And Strategies - Global Forecast To 2023
View Report
Sterilization Equipment and Disinfectants Market - By Type Of Products (Sterilization Equipment, Disinfectants), By Method (Physical Method, Chemical Method, Mechanical Method), By End User (Hospitals And Clinics, Clinical Laboratories, Pharmaceutical Companies, Other Industries, Non-Industrial Use ), And By Region, Opportunities And Strategies - Global Forecast To 2023
View Report
Respiratory Masks (N95 Respirators, Surgical Masks, And Others) Market - By Type (N95 Respirators, Common Grade Surgical Masks And Non-Medical Grade Respiratory Masks), By End-User (Hospitals And Clinics, Individual, Industrial, And Others), By Distribution Channel (Hospitals, Retail And Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Portable Ultrasound Devices Market - By Segments (Mobile Ultrasound Devices And Handheld Ultrasound Devices), By End User ( Cardiovascular, Obstetrics / Gynecology, Gastro, Musculoskeletal And Point Of Care / Others), And By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
Portable X-Ray Devices Market - By Segments (Mobile X-Ray Devices, Handheld X-Ray Devices), By Types (Computed Radiography X-Ray Devices, Digital X-Ray Devices And Analog X-Ray), And By Region, Opportunities And Strategies – Global Forecast To 2022
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)